Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
F-18-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases
F-18-FDG PET/CT findings in a case of a semantic variant of primary progressive aphasia
F-18-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non-small Cell Lung Cancer
F-18-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
F-18-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?
F-18-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer
F-18-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen
F-18-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer
F-18-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab
F-18-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas
F-18-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer%26apos;s disease
F-18-FDG and F-18-FLT PET/CT imaging in the characterization of mediastinal lymph nodes
F-18-fluorodeoxyglucose PET/CT added to screening after unprovoked VTE did not increase cancer detection
F-18-Mefway PET Imaging of Serotonin 1A Receptors in Humans: A Comparison with F-18-FCWAY (vol 10, e0121342, 2015)
F-18-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial
F-18-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumor
F-18-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer
F-18-FDG Uptake in Ischemic Colitis During Follow-up of a Patient With Lung Cancer
F-18-FDG PET/CT Features of Chronic Sclerosing Sialadenitis Presenting as Localized IgG4-Related Disease
F-18-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients
F-18-FDG PET/CT Volumetric Parameters are Associated with Tumor Grade and Metastasis in Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease
F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature
F-18-FDG PET/CT as predictor of tumour biology and prognosis in epithelial ovarian carcinoma
F-18-fluorothymidine PET imaging in gliomas: an update
F-18-Fluorodeoxyglucose PET/MR Imaging in Lymphoma
F-18-Fluoride PET/CT Allows Detection of Hyperostosis and Osseous Involvement in Meningioma Initial Experience
F-18-click labeling and preclinical evaluation of a new F-18-folate for PET imaging
F-18-FDG PET/CT diagnosis of liver cyst infection in a patient with autosomal dominant polycystic kidney disease and fever of unknown origin
F-18-FDG PET and intravascular ultrasonography (IVUS) images compared with histology of atherosclerotic plaques: F-18-FDG accumulates in foamy macrophages
F-18-FDG-PET/CT Imaging to Diagnose Septic Emboli and Mycotic Aneurysms in Patients with Endocarditis and Cardiac Device Infections
F-18-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer
F-18-FDG PET/CT and sentinel lymph node biopsy in the staging of patients with cervical and endometrial cancer. Role of dual-time-point imaging
F-18-Labeling of Sensitive Biomolecules for Positron Emission Tomography
F-18-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with F-18-FDG
F-18-AIF Labeled Peptide and Protein Conjugates as Positron Emission Tomography Imaging Pharmaceuticals
F-18-labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer
F-18-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer
F-18-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study
F-18-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model
F-18-Fluorocholine Uptake and Positron Emission Tomography Imaging in Rat Peritoneal Endometriosis
F-18-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test-Retest Reproducibility and Quantification of Neuroinflammation
F-18-FDG-PET/CT as adjunctive diagnostic modalities in canine fever of unknown origin
F-18-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with Tc-99m-MIBI or Tc-99m-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients
F-18-fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
F-18-Fluorodeoxyglucose Positron Emission Tomography 10 Days Before Onset of Aortic Dissection
F-18-FDG-PET/CT: an accurate method to assess the activity of Takayasu's arteritis
F-18-FDG PET image biomarkers improve prediction of late radiation-induced xerostomia
F-18-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients
F-18-NaF PET/CT for the evaluation of temporomandibular joint disorder
F-18-FDG PET/CT helps in unmasking the great mimicker: A case of neurosarcoidosis with isolated involvement of the spinal cord
F-18-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy
F-18-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma
F-18-Fluoride PET/CT and Tc-99m-MDP SPECT/CT can detect bone cancer at early stage in rodents
F-18-FDG PET/CT can predict chemosensitivity and proliferation of epithelial ovarian cancer via SUVmax value